Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?

Front Oncol. 2023 Jul 31:13:1247808. doi: 10.3389/fonc.2023.1247808. eCollection 2023.

Authors

Mattia D'Agostino¹, Carolina Terragna², Mark van Duin³

Affiliations

¹ SSD Clinical Trial in Oncoematologia e Mieloma Multiplo, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.
² IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
³ Department of Haematology, Erasmus Medical Center, Rotterdam, Netherlands.

No abstract available

Keywords: liquid biopsy; minimal residual disease; multiple myeloma; prognosis; risk assessment.

Publication types

Editorial